No. | Sex | Age | Primary disease | Presentation | Histology | Location | Past therapy | Size (cm) | Interval between studies (days) | Tumor SUVmax | Tumor TNR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11C-Met | 18F-BPA | 11C-Met | 18F-BPA | ||||||||||
1 | M | 20 | Facial RBD | NT | RBD | orbit | Noa | 3.2 × 3.0 to 4.5 × 5.0b | 123 | 3.7 | 3.6 | 3.8 | 3.9 |
2 | M | 20 | Facial RBD | LR | RBD | MS | PO/CRT | 2.5 × 1.5 | 5 | 1.5 | 1.6 | 1.1 | 1.3 |
3 | M | 27 | Lingual | LR | SCC | Lingual | PO/CRT | 3.2 × 4.1 | 16 | 6.6 | 4.2 | 4.6 | 3.1 |
4 | M | 50 | EAC cancer | LR | SCC | EAC | PO /CRT | 3.3 × 4.4 | 2 | 4.4 | 4.1 | 3.1 | 2.9 |
5 | M | 47 | Parotid gland ACC | LR | ACC | Parotid gland | PO /CRT | 2.0 × 2.3 | 2 | 5.6 | 5.6 | 5.1 | 2.7 |
6 | M | 47 | Nasal melanoma | NT | Melanoma | Nasal cavity | No | 3.1 × 3.2 | 4 | 5.8 | 4.7 | 4.1 | 3.9 |
7 | F | 66 | Lacrimal ACC | M | ACC | MS | PO /CRT | 3.3 × 2.2 | 6 | 4.7 | 3.6 | 2 | 2.2 |
Average | 5 (median) | 4.6 ± 1.7 (mean) | 3.9 ± 1.2 (mean) | 3.4 ± 1.4 (mean) | 2.9 ± 0.9 (mean) |